Cagrilintide + Semaglutide Combination
Cagrilintide + Semaglutide Combination is a high-purity research-grade compound manufactured under controlled quality conditions for pharmaceutical research applications. Available specification: 5 mg+5 mg, 10 mg. This product is intended exclusively for research purposes and as a pharmaceutical raw material for qualified institutions.
Specifications
| CAS Number | 2381261-40-9 / 910463-68-2 |
|---|---|
| Molecular Formula | C152H247N43O47 / C187H291N45O59 |
| Molecular Weight | 3414.94 / 4113.58 g/mol |
| Physical Appearance | White to off-white lyophilized |
Packaging Options
Product Overview
Cagrilintide + Semaglutide Combination is classified as a multi-component peptide research kit within the category of pharmaceutical-grade research materials. This product is manufactured to meet stringent quality specifications established for biochemical research reagents and pharmaceutical raw materials.
Structural Characteristics
Manufacturing & Purification
| Synthesis Method | Solid-phase peptide synthesis (SPPS) using Fmoc-protected amino acids |
|---|---|
| Purification | Preparative RP-HPLC with C18 stationary phase, water/acetonitrile gradient |
| Final Processing | Sterile filtration (0.22 μm) and controlled lyophilization |
Quality Control Testing
| Identity | ESI-MS or MALDI-TOF mass spectrometry confirmation |
|---|---|
| Purity | RP-HPLC analysis ≥99% |
| Composition | Amino acid analysis following acid hydrolysis |
| Water Content | Karl Fischer titration <3% |
| Endotoxin | LAL method <0.5 EU/mg |
| Documentation | Certificate of Analysis (COA) provided with each lot |
Storage & Handling
Lyophilized Powder
- Store at -20°C ± 5°C
- Protected from light and moisture
- Stable for 24 months when properly stored
Reconstituted Solution
- Short-term: 2-8°C for up to 7 days
- Long-term: -20°C for up to 30 days
- Aliquot to minimize freeze-thaw cycles
Shipping
- Cold chain transport at 2-8°C
- Dry ice recommended for extended transit
- Temperature monitoring included
Research Applications
Cagrilintide + Semaglutide Combination is positioned within the pharmaceutical supply chain as a research-grade combination kit designed for comparative studies and multi-component experimental protocols. The product is suitable for in vitro biochemical investigations, binding assay development, formulation studies, and analytical method validation. Each component includes individual Certificate of Analysis documentation enabling independent traceability and quality verification. This product is supplied exclusively for research purposes and as pharmaceutical raw material to qualified research institutions, academic laboratories, and licensed manufacturers operating under applicable regulatory frameworks. Not intended for human or veterinary diagnostic or therapeutic use.
Typical applications include: Receptor binding studies, structure-activity relationship investigations, analytical method development, stability studies, and pharmaceutical formulation research.
For Research Use Only. This product is intended for research and pharmaceutical raw material applications only. Not for human or veterinary diagnostic or therapeutic use. Handle according to applicable safety guidelines and regulations.
| Product Name | Cagrilintide + Semaglutide Combination |
|---|---|
| CAS Number | 2381261-40-9 / 910463-68-2 |
| Molecular Formula | C152H247N43O47 / C187H291N45O59 |
| Molecular Weight | 3414.94 / 4113.58 g/mol |
| Physical Appearance | White to off-white lyophilized |
| Solubility | Soluble in sterile water, PBS |
| Purity (HPLC) | ≥99% (by HPLC) |
| Storage Conditions | -20°C ± 5°C, protected from light |
Related Products
Need a Custom Quote?
Get competitive pricing for bulk orders. Our team responds within 12 business hours.